Chronic Congestive Heart Failure

Populations and Risk Factors

Adults over 65 are the primary population; prevalence doubles with each decade after age 45
History of coronary artery disease, atherosclerosis, or prior myocardial infarction (ischemic cardiomyopathy is the most common cause)
Chronic hypertension — sustained afterload increase leads to ventricular hypertrophy and eventual failure
Valvular heart disease (stenosis or regurgitation) — chronic volume or pressure overload
Diabetes mellitus — 2–5 times increased risk of developing CHF; diabetic cardiomyopathy
Heavy alcohol use (alcoholic cardiomyopathy) or illicit drug use (cocaine, methamphetamine)
Congenital heart defects reaching adulthood
Obesity, sedentary lifestyle, smoking
African American and Hispanic populations have higher incidence and poorer outcomes
Male sex slightly higher overall, but women develop CHF at older ages and have more preserved ejection fraction (HFpEF)

Causes and Pathophysiology

Pump Failure Mechanism

CHF is not a single disease but a syndrome resulting from any structural or functional cardiac disorder that impairs ventricular filling or ejection
Systolic failure (HFrEF — heart failure with reduced ejection fraction): weakened ventricular contraction, EF <40%; the ventricle cannot eject sufficient blood forward; most commonly from ischemic damage (MI) or dilated cardiomyopathy
Diastolic failure (HFpEF — heart failure with preserved ejection fraction): stiff, noncompliant ventricle that cannot fill adequately during diastole; EF may be normal (>50%); most commonly from chronic hypertension causing ventricular hypertrophy and fibrosis
Regardless of type, the result is the same: reduced cardiac output triggers a cascade of neurohormonal compensation that initially maintains perfusion but ultimately accelerates disease progression

Neurohormonal Compensation Cascade

Reduced cardiac output is detected by baroreceptors, activating the sympathetic nervous system (SNS) — increased heart rate, contractility, and peripheral vasoconstriction
Reduced renal perfusion activates the renin-angiotensin-aldosterone system (RAAS) — angiotensin II causes vasoconstriction and aldosterone promotes sodium and water retention
Combined effect: blood volume increases (preload), peripheral resistance increases (afterload), and the failing heart must work harder against both — a vicious cycle
Over time, sustained SNS activation causes myocyte toxicity and remodeling; sustained RAAS activation causes myocardial fibrosis and further stiffening
This is why CHF medications (ACE inhibitors, ARBs, beta-blockers, diuretics, aldosterone antagonists) target these compensatory mechanisms

Left-Sided vs. Right-Sided Failure

Left-sided failure: blood backs up into the pulmonary circulation — pulmonary congestion, dyspnea, orthopnea, paroxysmal nocturnal dyspnea, crackles on auscultation, chronic productive cough; accessory muscles of respiration become chronically overloaded from increased work of breathing
Right-sided failure: blood backs up into the systemic venous circulation — peripheral dependent edema (ankles, legs, sacrum in bed-bound patients), hepatomegaly, jugular venous distension (JVD), ascites, weight gain from fluid retention
Most patients develop biventricular failure: left-sided failure increases pulmonary pressure, which overloads the right ventricle, producing combined left and right signs
Cardiac cachexia in end-stage disease: severe muscle wasting from chronic elevated metabolic demand, reduced intestinal absorption (bowel wall edema), and cytokine-mediated catabolism

MSK and Respiratory Consequences

Dependent edema: chronic elevated venous pressure in the systemic circuit produces sustained pitting edema; severity reflects disease stability — worsening edema indicates decompensation
Respiratory muscle fatigue: chronic pulmonary congestion increases airway resistance and reduces lung compliance, requiring increased respiratory effort; accessory muscles of respiration (SCM, scalenes, pectoralis minor, upper trapezius, intercostals) become chronically hypertonic from sustained overwork
Thoracic restriction: chronic increased work of breathing, persistent cough, and muscle guarding reduce thoracic cage mobility; intercostal muscles become fibrotic; costovertebral joint play decreases
Deconditioning: reduced cardiac output limits exercise tolerance; the patient self-limits activity, leading to generalized muscle atrophy and further cardiovascular deconditioning — a reinforcing cycle

Signs and Symptoms

NYHA Functional Classification

Class	Symptoms	Clinical Significance for MT
Class I	No symptoms with ordinary activity; no limitation	Standard treatment with monitoring
Class II	Mild symptoms with ordinary activity; slight limitation	Modified treatment; monitor for fatigue
Class III	Marked limitation; comfortable at rest but symptomatic with less-than-ordinary activity	Shortened sessions; semi-reclined; close monitoring
Class IV	Symptoms at rest; unable to carry on any physical activity without discomfort	Palliative care only; very gentle; may be contraindicated if unstable

General Presentation

Fatigue and exercise intolerance — disproportionate to activity level; the earliest and most consistent symptom
Dyspnea on exertion progressing to dyspnea at rest in advanced disease
Orthopnea — difficulty breathing while lying flat; patient sleeps propped on multiple pillows
Paroxysmal nocturnal dyspnea — sudden nighttime breathlessness from fluid redistribution when supine
Peripheral pitting edema — bilateral, dependent (ankles when upright, sacrum when recumbent); progression from trace to severe correlates with fluid status
Distended jugular veins (JVD) — visible above the clavicle with the patient at 45 degrees
Rapid or irregular pulse (tachycardia, atrial fibrillation)
Cyanosis of lips and nail beds in advanced disease
Chronic productive cough (left-sided congestion); pink frothy sputum indicates pulmonary edema (acute decompensation)
Rapid weight gain (>2 lbs in 24 hours or >5 lbs in a week) — index of fluid retention
Cold, clammy skin from peripheral vasoconstriction (compensatory)
Nocturia — fluid redistribution when supine promotes renal perfusion and diuresis at night

Assessment Profile

Subjective Presentation

Chief complaint: "I get winded just walking across the room," "My ankles swell up by the end of the day," "I can't lie flat without feeling like I'm drowning," or "I'm just so tired all the time" — fatigue, dyspnea, and edema are the dominant concerns
Pain quality: not typically a pain-dominant condition; discomfort from edema (heavy, tight, swollen feeling in legs); chest tightness or heaviness from pulmonary congestion; musculoskeletal discomfort from deconditioning and compensatory breathing patterns; muscle cramping from diuretic-induced electrolyte imbalances
Onset: gradual progression over months to years; acute-on-chronic exacerbations may follow dietary indiscretion (high sodium), medication non-compliance, intercurrent illness, or cardiac event; obtain NYHA class, current medication regimen, last cardiology visit, and baseline exercise tolerance
Aggravating factors: physical exertion (even minimal in Class III–IV); lying flat (orthopnea); high sodium intake; fluid overload; heat and humidity; emotional stress; skipped medications
Easing factors: rest; elevation of the head and trunk (semi-reclined position); elevation of edematous limbs; diuretic medication; cool environment; paced activity with frequent rest breaks
Red flags: acute dyspnea at rest, pink frothy sputum (pulmonary edema), new or worsening bilateral edema, rapid weight gain (>2 lbs/24 hrs), persistent cough with frothy sputum, confusion or altered mental status, chest pain, syncope — acute decompensation requiring emergency medical evaluation; do not treat

Observation

Local inspection: bilateral pitting edema of ankles and lower legs (staging: trace, 1+ mild, 2+ moderate, 3+ severe, 4+ massive); sacral edema in bed-bound patients; JVD visible above the clavicle at 45-degree head elevation; cyanosis of lips and nail beds; skin may appear shiny and taut over edematous areas; accessory muscle use during quiet breathing (SCM, scalenes visible with each breath)
Posture: forward lean in seated position to optimize respiratory mechanics (tripod position in severe cases); elevated shoulders from chronic accessory muscle use; reduced thoracic kyphosis mobility; may sit with legs dependent (exacerbates edema but avoids orthopnea)
Gait: slow, deliberate pace; frequent stops to rest (exercise intolerance); may use assistive device in advanced disease; shuffling pattern from deconditioning and peripheral edema

Palpation

Tone: chronic hypertonicity in accessory muscles of respiration — SCM, scalenes, pectoralis minor, upper trapezius, intercostals — from sustained increased work of breathing; these muscles are fatigued and fibrotic in long-standing CHF; generalized deconditioning in the limbs (reduced muscle mass, poor tone)
Tenderness: accessory muscles of respiration are typically tender from chronic overwork; intercostal muscles may be tender from persistent cough; edematous tissue may be tender from stretched skin and subcutaneous congestion; calf tenderness in the presence of unilateral edema must be evaluated for DVT before proceeding
Temperature: cool peripheral extremities (hands, feet) from compensatory vasoconstriction; warm, taut skin over severely edematous areas; temperature asymmetry between limbs warrants DVT screening
Tissue quality: pitting edema — apply sustained digital pressure over the medial malleolus or pretibial area for 5 seconds, then assess pit depth and rebound time (trace: barely perceptible pit; 1+: slight pit, rebounds quickly; 2+: 4 mm pit, rebounds in 10–15 seconds; 3+: 6 mm pit, rebounds in 15–30 seconds; 4+: 8+ mm pit, rebounds >30 seconds); tissue over chronically edematous areas may become thickened and fibrotic (brawny edema); general muscle wasting from deconditioning; cardiac cachexia in end-stage disease

Motion Assessment

AROM: thoracic rotation and lateral flexion reduced from chronic respiratory muscle tension and costovertebral stiffness; shoulder ROM may be limited by upper trapezius and pectoralis minor shortening; general exercise tolerance — the patient's ability to actively move through ROM may be limited by breathlessness rather than joint restriction (talk test: if the patient cannot maintain conversation during movement, cardiac workload is too high)
PROM / end-feel: costovertebral joint play restricted — stiff, guarded end-feel rather than capsular; thoracic extension may be limited with a muscular/guarding end-feel from chronic forward posture; peripheral joint ROM is typically intact unless edema is severe enough to produce mechanical restriction (massive edema limits ankle dorsiflexion through tissue bulk)
Resisted testing: generalized weakness from deconditioning; reduced grip strength; proximal muscle weakness greater than distal from chronic inactivity; no specific muscle pathology — weakness is systemic and functional

Special Test Cluster

The SOT cluster for chronic CHF is oriented toward safety monitoring and decompensation screening rather than musculoskeletal diagnosis. The cardiac diagnosis is established; the tests assess treatment safety.

Test	Positive Finding	Purpose
Pitting edema assessment (CMTO)	Grade 1+ to 4+ pitting; document location, depth, and rebound time; compare to previous visit	Monitor fluid status; worsening edema indicates decompensation; establishes baseline for tracking
Vital signs (pulse and respiratory rate) (CMTO)	Resting tachycardia >100 bpm, irregular rhythm, respiratory rate >24/min	Safety screen before every treatment — abnormal vitals at rest indicate decompensation; reduce intensity or reschedule
Orthostatic blood pressure test (CMTO)	Systolic drop ≥20 mmHg or diastolic drop ≥10 mmHg from supine to sitting/standing	Identifies medication-induced orthostatic hypotension; guides safe position changes during treatment
Jugular venous distension (JVD) observation (supplementary)	Visible JVD >3 cm above the clavicle at 45-degree head elevation	Indicates elevated right-sided venous pressure; worsening JVD suggests decompensation
Talk test (exercise tolerance) (supplementary)	Patient cannot maintain normal conversation during light activity or position changes	Simple functional assessment of cardiac reserve; if the patient is breathless during table transfers, the session should be very gentle and brief

Pre-treatment protocol: Resting pulse, respiratory rate, and edema assessment should be performed at the start of every session for CHF patients. Trends over multiple sessions are as important as single-session findings.

Differential Diagnoses

Condition	Key Distinguishing Feature
Acute decompensated CHF	Dyspnea at rest, pink frothy sputum, rapid-onset worsening edema, altered mental status — emergency referral; do not treat
Deep vein thrombosis	Unilateral calf swelling with warmth, redness, and deep tenderness; CHF edema is bilateral and symmetrical; unilateral edema in a CHF patient requires DVT screening before treatment
Chronic kidney disease (edema)	Bilateral edema also present; distinguish by periorbital edema (renal), reduced urine output, and elevated creatinine on labs; renal and cardiac edema may coexist
Cor pulmonale	Right-sided heart failure secondary to pulmonary disease (COPD, pulmonary hypertension); similar right-sided signs; distinguish by primary pulmonary history and left-sided findings
Hepatic edema (ascites)	Ascites, hepatomegaly, and lower extremity edema from portal hypertension; history of liver disease; distinguish by abdominal distension and hepatic stigmata

CMTO Exam Relevance

CMTO Appendix category A7 (Systemic Conditions — Cardiovascular)
Critical rule: mechanically pushing fluid through the circulatory system is strictly contraindicated — the failing heart cannot handle additional venous return; no MLD, no vigorous circulatory effleurage, no leg elevation if it worsens dyspnea
Medications cause significant side effects: ACE inhibitors and beta-blockers cause orthostatic hypotension; diuretics cause electrolyte imbalances and frequent urination; digoxin has a narrow therapeutic window; anticoagulants require reduced pressure
Cardiac cachexia in end-stage cases produces extreme muscle wasting requiring minimal pressure
Know NYHA classification — it determines treatment intensity and session length
Orthopnea prevents comfortable supine positioning; semi-reclined or side-lying required
Rapid weight gain (>2 lbs/24 hrs) is a decompensation indicator requiring medical referral

Massage Therapy Considerations

Primary therapeutic target: respiratory muscle fatigue (accessory muscles chronically hypertonic from increased work of breathing), thoracic cage restriction (costovertebral stiffness, intercostal fibrosis), deconditioning-related MSK discomfort, and stress reduction — massage cannot improve cardiac function but can address the musculoskeletal consequences of chronic cardiopulmonary compromise
Sequencing logic: perform vital sign screening first (pulse, respiratory rate, edema assessment); address respiratory accessory muscles to improve breathing mechanics; then treat general musculoskeletal discomfort; keep the overall treatment gentle, paced, and short; no vigorous techniques at any point
Safety / contraindications: mechanically pushing fluid through the circulatory system is strictly contraindicated — no lymphatic drainage, no vigorous effleurage directed toward the heart, no deep circulatory techniques; do not elevate legs if it worsens dyspnea (fluid mobilizes toward the lungs); anticoagulant use (warfarin, DOACs) requires reduced pressure and no deep tissue work; reschedule if resting vitals are abnormal (tachycardia >100, respiratory rate >24, new or worsening edema); cardiac cachexia requires extremely light pressure
Heat/cold guidance: avoid hot immersion baths and sauna (increases cardiac workload through peripheral vasodilation and tachycardia); mild warmth for comfort on musculoskeletal areas is acceptable; avoid sustained cold applications that trigger vasoconstriction and increase afterload; temperature extremes in either direction stress the cardiovascular system

Treatment Plan Foundation

Clinical Goals

Reduce hypertonicity in accessory muscles of respiration (SCM, scalenes, pectoralis minor, intercostals)
Improve thoracic cage mobility and breathing mechanics
Provide stress reduction and parasympathetic engagement
Monitor and document edema status at each visit

Position

Semi-reclined (30–45 degree head elevation) is the primary position — prevents orthopnea and fluid mobilization to the lungs; use the table's head elevation or multiple pillows behind the trunk
Side-lying is acceptable and may be preferred for posterior access
Never force supine if the patient experiences orthopnea
Elevate legs only if tolerated — test cautiously; in some CHF patients, leg elevation rapidly mobilizes fluid toward the pulmonary circulation and worsens dyspnea; ask the client and observe respiratory response
Allow extra time for position changes — orthostatic hypotension from medications means transitions must be slow and supported

Session Sequence

Vital sign check — resting pulse and respiratory rate; pitting edema assessment bilaterally; compare to previous session; if pulse >100, respiratory rate >24, or edema has significantly worsened, discuss with the client and consider rescheduling
General relaxation effleurage to accessible areas — gentle, rhythmic, slow; establish parasympathetic tone; avoid vigorous strokes that increase venous return
Sustained compression and myofascial release to SCM and scalenes bilaterally — these are the primary overloaded accessory muscles; work gently within pain-free tolerance
Pectoralis minor release — address anterior shoulder tightness and its contribution to restricted thoracic expansion; access through the anterior axillary fold
Intercostal muscle release — gentle sustained pressure between ribs to reduce fibrotic restriction; work through accessible intercostal spaces; improves chest wall compliance
Upper trapezius and levator scapulae release — address compensatory shoulder elevation from chronic accessory muscle breathing
General relaxation massage to upper extremities and accessible areas — gentle effleurage and light petrissage; maintain the calming, paced quality throughout; session duration 30 to 45 minutes maximum

Adjunct Modalities

Hydrotherapy: mild warmth (warm towels, not hot) to cervical and shoulder regions before accessory muscle work for comfort; avoid hot immersion baths, steam, and sauna — increases cardiac workload; avoid sustained cold to the extremities — vasoconstriction increases afterload; temperature modalities should be mild and brief

Exam Station Notes

Perform vital sign check (pulse, respiratory rate) before treatment — demonstrate that safety monitoring is part of your protocol
Document edema grade and compare to previous — show trending awareness, not just single-point assessment
Position the client semi-reclined — the examiner expects to see orthopnea awareness
Explain why vigorous circulatory massage is contraindicated — the failing heart cannot handle increased venous return
Allow extra time for position transitions — demonstrate orthostatic hypotension awareness

Verbal Notes

Breathing and positioning: "I'm going to keep you in a semi-reclined position so you can breathe comfortably. If at any point you feel short of breath or uncomfortable, please tell me immediately and we'll adjust."
Leg elevation: "I'd like to support your legs slightly elevated to help with the swelling. Let me know if this makes your breathing feel any different — some people feel more pressure in their chest."
Pacing: "This is going to be a gentle, relaxing session. If you feel tired or winded at any point, we can take a break or end early. There's no requirement to complete the full time."
Medication effects: "When we're done, I'll help you sit up slowly. Your medications can sometimes cause dizziness when changing positions, so we'll take our time."

Self-Care

Daily self-monitoring: weigh daily at the same time; report weight gain >2 lbs in 24 hours or >5 lbs in a week to physician immediately
Edema management: elevate legs when sitting (only if tolerated without dyspnea); avoid prolonged standing; compression stockings as recommended by physician
Gentle diaphragmatic breathing exercises — 5 minutes twice daily; promotes efficient breathing pattern and reduces accessory muscle overload
Paced daily activity — short walks with rest breaks; avoid sudden exertion; the "talk test" guides safe intensity (if you cannot maintain conversation, slow down or stop)

Key Takeaways

Mechanically pushing fluid through the circulatory system is strictly contraindicated in CHF — no MLD, no vigorous circulatory effleurage; the failing heart cannot process additional venous return
Position clients semi-reclined (30–45 degrees); orthopnea prevents comfortable supine positioning; leg elevation may worsen dyspnea by mobilizing fluid to the lungs
Monitor vital signs before every treatment: tachycardia (>100 bpm), irregular rhythm, or respiratory rate >24/min at rest indicate decompensation requiring rescheduling or referral
Track pitting edema at each visit (grade, location, rebound time); worsening edema or rapid weight gain (>2 lbs/24 hrs) indicates decompensation requiring urgent medical evaluation
CHF medications (ACE inhibitors, beta-blockers, diuretics, digoxin, anticoagulants) cause orthostatic hypotension, electrolyte imbalances, and bleeding risk — allow extra time for position transitions and reduce pressure with anticoagulant use
Accessory muscles of respiration (SCM, scalenes, pectoralis minor, intercostals) are chronically hypertonic from increased work of breathing — these are the primary MT treatment targets
Keep sessions gentle and short (30–45 minutes); avoid heat and cold extremes; the treatment itself must not increase cardiac workload
Acute decompensation (dyspnea at rest, pink frothy sputum, confusion, new bilateral edema) is a medical emergency — do not treat